Pfizer to Acquire Obesity Drug Start-Up Metsera in $10 Billion Deal

The announcement of the deal signaled an end to the bidding war for Metsera between Pfizer and Novo Nordisk, the Danish maker of Ozempic and Wegovy.

News
Rise in Kidney Disease Tied to Other Chronic Conditions, Study Finds

Rates of the disease have been rising for decades, driven in part by diabetes and high blood pressure.

News
What Trump’s New Drug Pricing Deal Means for People With Obesity

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

News
Trump Announces Deal to Drop Obesity Drug Prices to as Little as $150 a Month

President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.

News
Costco to Sell Ozempic and Wegovy, Weight-Loss Wonder Drugs

Costco members will pay $499 a month out of pocket, the same price offered at CVS and Walmart, and on the manufacturer’s direct-to-consumer website.

News
Why Obesity Is Killing American Men

Men seek weight loss treatment far less often than women. Doctors are concerned.

News
More Children Are Now Obese Than Underweight, UN Report Finds

One in 10 children worldwide now has obesity, a report from UNICEF found, and the number of overweight children has more than doubled in low- and middle-income countries since 2000.

News
Loose Skin After Weight Loss: What Experts Want You to Know

Obesity drugs are leaving more people with loose, sagging skin. But firming creams and body contouring treatments are largely a pipe dream, experts say.

News
Mediterranean Diet Reduces Diabetes Risk, Study Shows

Strong evidence suggests that following the diet, cutting calories and exercising lowers the chances of developing diabetes for those with metabolic risk factors.

News
Wegovy Gets F.D.A. Approval for MASH

Wegovy has been approved for use among the growing number of Americans who have MASH.

News